Our response to Covid-19
The Eosinophilic Family Coalition (EFC) is closely monitoring any developments regarding the coronavirus (COVID-19) pandemic and the potential impact on the higher-risk patients in the eosinophilic gastrointestinal diseases (EGID) community. This situation is changing rapidly and we encourage you to follow updates on the Centers for Disease Control and Prevention (CDC) website as well as your local and state health departments website.
Cegir and Covid-19
On behalf of the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR), we want to reassure all of you during this time of COVID-19 that we are here for you in this unprecedented time. This video is a message Dr. Marc Rothenberg & Dr. Glenn Furuta created on behalf of CEGIR for patients in regard to COVID-19.
Marc Rothenberg, MD, PhD
Director, Cincinnati Center for Eosinophilic Disorders (CCED), Cincinnati Children’s
Glenn Furuta, MD
Clinical Team Liaison, CEGIR
Director, Gastrointestinal Eosinophilic Diseases Program,
Children’s Hospital Colorado
The NIH has issued an exciting News Release about the COVID Rare Disease Survey/Registry, Please use this as an opportunity to advertise the survey via your social media venues. I am attaching an IRB approved flyer and COVID image that can be shared over social media. Let me know if you have any questions.
Publication: Eosinophil Responses During COVID-19 Infection and Coronavirus Vaccination
This study looks at the following:
First, do patients with eosinophilia-associated diseases have an altered course of COVID-19? Second, do patients with eosinopenia (now intentionally induced by biological drugs) have unique COVID-19 susceptibility and/or disease course?
Tips for maintaining mental health during Covid-19